Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.

Experimental hematology - 1 Jul 2011

Wang Yongming, Langer Nathaniel B, Shaw George C, Yang Guang, Li Liangtao, Kaplan Jerry, Paw Barry H, Bloomer Joseph R

Abstract excerpt

OBJECTIVE: Most patients with erythropoietic protoporphyria have deficient ferrochelatase (FECH) activity due to changes in FECH DNA. We evaluated seven patients with erythropoietic protoporphyria phenotype in whom abnormalities of FECH DNA were not found by conventional analysis. The major focus...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to 5-Aminolevulinate Synthetase
Share to Cation Transport Proteins
Share to Embryo, Nonmammalian

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Ferrochelatase

Share to K562 Cells

Share to Protoporphyria, Erythropoietic

Share to Xenopus

Share to Yeasts

Source

Open in PubMed Open full text

Identifiers

PMID: 21627978
DOI: 10.1016/j.exphem.2011.05.003
PMCID: PMC3143264

Genes

FECH
ALAS2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 4 Sept 2026. Prepared record publication-21627978-2026-09-04.2. Manifest publication-graph-cohort-2026-09-04.2.

Source receipt: PubMed via Helena Literature Corpus, retrieved 4 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Abnormal mitoferrin-1 expression in patients with erythropoietic protoporphyria.PMID 21627978Read ↗

Loss-of-function ferrochelatase and gain-of-function erythroid-specific 5-aminolevulinate synthase mutations causing erythropoietic protoporphyria and x-linked protoporphyria in North American patients reveal novel mutations and a high prevalence of X-linked protoporphyria.Semantic proximity Read ↗

Iron regulatory protein-1 protects against mitoferrin-1-deficient porphyria.Semantic proximity Read ↗

The molecular genetics of erythropoietic protoporphyria.Semantic proximity Read ↗

Clinical implications of the molecular biology of erythropoietic protoporphyria.Semantic proximity Read ↗

Systematic analysis of molecular defects in the ferrochelatase gene from patients with erythropoietic protoporphyria.Semantic proximity Read ↗

Erythropoietic protoporphyria: identification of novel mutations in the ferrochelatase gene and comparison of biochemical markers versus molecular analysis as diagnostic strategies.Semantic proximity Read ↗

Mutations in the iron-sulfur cluster ligands of the human ferrochelatase lead to erythropoietic protoporphyria.Semantic proximity Read ↗

Mitoferrin is essential for erythroid iron assimilation.Semantic proximity Read ↗

Ferrochelatase gene mutations in erythropoietic protoporphyria: focus on liver disease.Semantic proximity Read ↗

New insights into the pathogenesis of erythropoietic protoporphyria and their impact on patient care.Semantic proximity Read ↗

Overexpression of <i>Drosophila mitoferrin</i> in l(2)mbn cells results in dysregulation of Fer1HCH expressionSemantic proximity Read ↗

Evidence in the UK Biobank for the underdiagnosis of erythropoietic protoporphyria.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.